Interferon beta-1a vs. glatiramer acetate: changes of innate immunity in a group of women with multiple sclerosis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F23%3A10476190" target="_blank" >RIV/00669806:_____/23:10476190 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/23:00133490 RIV/00216208:11140/23:10476190 RIV/00216208:11150/23:10476190 RIV/00179906:_____/23:10476190
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7aCZeq4iCo" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7aCZeq4iCo</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1159/000532022" target="_blank" >10.1159/000532022</a>
Alternative languages
Result language
angličtina
Original language name
Interferon beta-1a vs. glatiramer acetate: changes of innate immunity in a group of women with multiple sclerosis
Original language description
Introduction: Multiple sclerosis is a chronic inflammatory autoimmune demyelinating disease that secondarily leads to the axonal loss and associated brain atrophy. Disease-modifying drugs (DMDs) have previously been studied for their ability to affect specific immunity. This study investigates the effect of interferon beta-1a (INF) and glatiramer acetate (GA) administration on changes in innate immunity cell populations. Methods: Sixty Caucasian female patients with relapsing-remitting multiple sclerosis undergo blood sample testing for 15 blood parameters at baseline, 1M, 3M and 6M after treatment by GA or IFN (started as their first line DMD). Results: A statistically significant difference in the change after 6 months was found in the parameter monocytes (relative count) in the group of patients treated with IFN. The median increase was 27.8%. Changes in many of the other 15 parameters studied were 10-20%. Conclusion: Innate immunity has long been neglected in MS immunopathology. The findings of this study show that innate immunity cells, especially monocytes may contribute significantly to MS immunopathology.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Neurology
ISSN
0014-3022
e-ISSN
1421-9913
Volume of the periodical
86
Issue of the periodical within the volume
5
Country of publishing house
CH - SWITZERLAND
Number of pages
7
Pages from-to
334-340
UT code for WoS article
001036985900001
EID of the result in the Scopus database
2-s2.0-85176495640